Astaxanthin (ATX)

Nutraceutical · EXACT ENTITY MATCH. CHEMBL1255871, max_phase 3, first_approval NULL (food-grade carotenoid, never a registered drug), natural_product=true, therapeutic_flag=false, not withdrawn. get_mechanism mec_id 9399 gives only a descriptive pharmacological class with target_chembl_id and action_type NULL IN CHEMBL ITSELF, so the empty target field is a genuine null rather than an omission. 5 of 10 raw trial hits were kept as genuinely astaxanthin-containing; REJECTED as term-collision or multi-ingredient false positives: NCT01647984 Ritmonutra, NCT07604870 and NCT06880939 krill oil, NCT01562080 Armolipid Plus, NCT04071977 undefined combined antioxidant therapy. Indications are diabetic neuropathy, male infertility, knee osteoarthritis, bioavailability and PCOS; NONE is a trauma indication. NCT05138549 is TERMINATED at n=16.